FDA approves Vyalev for advanced Parkinson's disease
The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with ...
HealthDay on MSN2d
FDA Approves Vyalev for Advanced Parkinson Disease
The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced ...
PharmTech1d
FDA Approves AbbVie Therapy for Adults with Advanced Parkinson’s Disease
Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.
Spokane woman gets back her ‘normal life’ from newly approved Parkinson’s disease treatment
Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...
Pharmabiz6d
AbbVie’s Vyalev receives US FDA approval to treat adults living with advanced Parkinson's disease
North Chicago, Illinois Saturday, October 19, 2024, 12:00 Hrs [IST] ...
McKnight's Long-Term Care News6d
A new treatment option gets FDA approval for adults with advanced Parkinson’s disease
The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...
GlobalData on MSN17h
AbbVie and Richter partner for neuropsychiatric treatments
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
AbbVie: Expect A Beat-And-Raise Q3 2024
AbbVie should report strong Q3 2024 results next week and increase the full-year guidance. Explore more details here.
InnovationRx: Regrowing Cartilage To Fix Damaged Knees And Ankles
Plus: Groupon cofounder’s healthcare venture, investments in CAR-T therapies and the upcoming Forbes Healthcare Summit.
emjreviews.com6d
24-Hour Therapy for Parkinson’s: The First Of Its Kind
The U.S. FDA has approved the first 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease.
TipRanks on MSN5d
Allergan’s BOTOX Cosmetic gets FDA approval in jaw-neck bands
Allergan Aesthetics, an AbbVie (ABBV) company, announced the U.S. FDA approval of BOTOX Cosmetic for temporary improvement in ...
pharmaphorum3d
AbbVie/Roche's Venclexta fails in confirmatory AML trial
AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Investigator sites are ...